Overview

Transforaminal Epidural Injection in Acute Sciatica

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Patients suffering from sciatica are treated conservatively for the first 8 weeks due to the favourable prognosis. This period is preferably extended up to 14-16 weeks after which patients may opt for surgery. However, patients may experience severe discomfort due to pain in the leg which can lead to decreased physical activity and socio-economic problems. An adequate therapy to alleviate symptoms during this period of 'wait-and-see' is lacking. In this study, patients will be randomized to treatment with transforaminal epidural injections or standard oral pain medication.
Phase:
N/A
Details
Lead Sponsor:
C.L.A.Vleggeert-Lankamp
Collaborators:
Posthumus Meyjes Fonds
Spaarne Gasthuis
Stichting Achmea Gezondheidszor
Treatments:
Dexamethasone
Lidocaine
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate